NO132157B - - Google Patents

Download PDF

Info

Publication number: NO132157B
Authority: NO; Norway
Prior art keywords: sera; serum; propiolactone; beta; way
Prior art date: 1973-06-25

Application number

NO2621/73A

Other languages

English (en)

Norwegian (no)

Other versions

NO132157C (de

NO262173L (de

Inventor

Thor Thorsen

Original Assignee

Sintef

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-06-25

Filing date

1973-06-25

Publication date

1975-06-16

1973-06-25 Application filed by Sintef filed Critical Sintef

1973-06-25 Priority to NO2621/73A priority Critical patent/NO132157C/no

1975-01-20 Publication of NO262173L publication Critical patent/NO262173L/no

1975-06-16 Publication of NO132157B publication Critical patent/NO132157B/no

1975-09-24 Publication of NO132157C publication Critical patent/NO132157C/no

Links

210000002966 serum Anatomy 0.000 claims description 15
241001465754 Metazoa Species 0.000 claims description 14
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 10
229960000380 propiolactone Drugs 0.000 claims description 9
238000000034 method Methods 0.000 claims description 4
239000000427 antigen Substances 0.000 claims description 3
102000036639 antigens Human genes 0.000 claims description 3
108091007433 antigens Proteins 0.000 claims description 3
239000002537 cosmetic Substances 0.000 claims description 3
238000002649 immunization Methods 0.000 claims description 3
230000003053 immunization Effects 0.000 claims description 3
239000011541 reaction mixture Substances 0.000 claims description 3
210000002257 embryonic structure Anatomy 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
229910052742 iron Inorganic materials 0.000 abstract 2
229910000831 Steel Inorganic materials 0.000 abstract 1
238000005554 pickling Methods 0.000 abstract 1
239000010959 steel Substances 0.000 abstract 1
238000002347 injection Methods 0.000 description 10
239000007924 injection Substances 0.000 description 10
238000006243 chemical reaction Methods 0.000 description 7
241000283973 Oryctolagus cuniculus Species 0.000 description 6
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 5
102000002322 Egg Proteins Human genes 0.000 description 5
108010000912 Egg Proteins Proteins 0.000 description 5
235000014103 egg white Nutrition 0.000 description 5
210000000969 egg white Anatomy 0.000 description 5
239000000725 suspension Substances 0.000 description 5
239000002504 physiological saline solution Substances 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
-1 egg white compound Chemical class 0.000 description 3
238000000605 extraction Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000013003 healing agent Substances 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
230000005906 menstruation Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000002674 ointment Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
239000000047 product Substances 0.000 description 1
229910052705 radium Inorganic materials 0.000 description 1
HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000007306 turnover Effects 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23G—CLEANING OR DE-GREASING OF METALLIC MATERIAL BY CHEMICAL METHODS OTHER THAN ELECTROLYSIS
- C23G1/00—Cleaning or pickling metallic material with solutions or molten salts
- C23G1/36—Regeneration of waste pickling liquors

Landscapes

Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Mechanical Engineering (AREA)
Metallurgy (AREA)
Organic Chemistry (AREA)
Cleaning And De-Greasing Of Metallic Materials By Chemical Methods (AREA)

NO2621/73A 1973-06-25 1973-06-25 NO132157C (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO2621/73A NO132157C (de)	1973-06-25	1973-06-25

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NO2621/73A NO132157C (de)	1973-06-25	1973-06-25

Publications (3)

Publication Number	Publication Date
NO262173L NO262173L (de)	1975-01-20
NO132157B true NO132157B (de)	1975-06-16
NO132157C NO132157C (de)	1975-09-24

Family

ID=19878979

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO2621/73A NO132157C (de)	1973-06-25	1973-06-25

Country Status (1)

Country	Link
NO (1)	NO132157C (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0339401A1 (de) *	1988-04-18	1989-11-02	Outokumpu Oy	Verfahren zur Regenerierung von Beizsäure, verwendet in einem Verfahren zur Beschichtung mit Zink

1973
- 1973-06-25 NO NO2621/73A patent/NO132157C/no unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0339401A1 (de) *	1988-04-18	1989-11-02	Outokumpu Oy	Verfahren zur Regenerierung von Beizsäure, verwendet in einem Verfahren zur Beschichtung mit Zink

Also Published As

Publication number	Publication date
NO132157C (de)	1975-09-24
NO262173L (de)	1975-01-20

Similar Documents

Publication	Publication Date	Title
Lindenmann et al.	1957	Studies on the production, mode of action and properties of interferon
Ambache	1951	Unmasking, after cholinergic paralysis by botulinum toxin, of a reversed action of nicotine on the mammalian intestine, revealing the probable presence of local inhibitory ganglion cells in the enteric plexuses
Best et al.	1931	Histamine
Hirsch et al.	1968	Effects of anti-thymocyte serum on Rauscher virus infection of mice
EP1236740A1 (de)	2002-09-04	Vakzine gegen Krebserkrankungen, die mit dem HER-2/neu Onkogen assoziiert sind
Ayo	1943	A toxic ocular reaction: I. New property of Shwartzman toxins
Noguchi et al.	1920	Immunological studies with a strain of Leptospira isolated from a case of yellow fever in Mérida, Yucatán
KR920002935B1 (ko)	1992-04-10	맥관 형성 저해제
IL28164A (en)	1971-11-29	Substituted ammonium basic addition salts of ribonucleic acid and their preparation
Baldwin	1955	Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats
NO132157B (de)	1975-06-16
Rosenheim	1909	The pressor principles of placental extracts
DE69432493T2 (de)	2003-10-30	Immunostimulierender Träger für Impfstoffe
Aptekman et al.	1951	Evidence of resistance to tumor graft in early stages of induced oncolysis
Meffert et al.	1966	Hormonal control of collateral circulation
RU2301667C1 (ru)	2007-06-27	Способ лечения заболеваний различной этиологии и травм различных органов
CN102212109B (zh)	2012-08-29	从骨肽注射剂中分离的骨多肽化合物及其应用
SINGER et al.	1926	Streptococcus Erysipelatis Toxin and Antitoxin
Des Ligneris et al.	1936	Clinical experiments on the effect of African snake venoms on human cancer cases with or without concomitant deep therapy
RU2077339C1 (ru)	1997-04-20	Иммуностимулятор
Schenkein	1971	The chemistry and biology of nerve growth factor
Nagler	1945	Treatment of experimental gas gangrene due to Clostridium welchii with penicillin and antitoxin
Ivanikov et al.	2002	Therapy of peptic ulcer with semax peptide
EA007839B1 (ru)	2007-02-27	Иммуностимулятор противоопухолевого действия и способ его получения
Fowweather et al.	1927	The Relation between Amino-Acids and the Wassermann Reaction